ZNF473
Basic information
Region (hg38): 19:50025714-50053414
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ZNF473 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 35 | 40 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 35 | 8 | 0 |
Variants in ZNF473
This is a list of pathogenic ClinVar variants found in the ZNF473 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-50039251-A-G | not specified | Uncertain significance (Sep 26, 2023) | ||
19-50041741-C-T | not specified | Uncertain significance (Mar 01, 2024) | ||
19-50041811-C-T | not specified | Uncertain significance (Jul 19, 2022) | ||
19-50044680-G-C | not specified | Uncertain significance (Jun 17, 2024) | ||
19-50044786-G-A | not specified | Uncertain significance (Feb 06, 2023) | ||
19-50044877-C-T | not specified | Uncertain significance (May 26, 2024) | ||
19-50044912-A-G | not specified | Uncertain significance (Jun 06, 2023) | ||
19-50044930-T-A | not specified | Uncertain significance (Jan 23, 2024) | ||
19-50045003-G-A | not specified | Uncertain significance (Apr 28, 2023) | ||
19-50045008-G-A | not specified | Uncertain significance (Jul 11, 2022) | ||
19-50045009-A-G | not specified | Uncertain significance (Dec 28, 2022) | ||
19-50045025-C-T | Likely benign (Sep 01, 2022) | |||
19-50045104-A-C | not specified | Uncertain significance (Apr 13, 2022) | ||
19-50045149-C-G | not specified | Uncertain significance (Jun 18, 2024) | ||
19-50045203-G-A | not specified | Uncertain significance (Jun 10, 2024) | ||
19-50045235-C-G | not specified | Uncertain significance (Sep 16, 2021) | ||
19-50045321-A-T | not specified | Uncertain significance (May 01, 2024) | ||
19-50045348-G-A | not specified | Uncertain significance (Jun 24, 2022) | ||
19-50045372-A-T | not specified | Uncertain significance (Mar 28, 2023) | ||
19-50045387-C-A | not specified | Uncertain significance (Dec 20, 2021) | ||
19-50045413-G-A | not specified | Uncertain significance (Oct 12, 2022) | ||
19-50045471-C-T | not specified | Uncertain significance (Jun 19, 2024) | ||
19-50045473-C-T | not specified | Uncertain significance (Oct 13, 2023) | ||
19-50045474-G-A | not specified | Likely benign (Jan 10, 2022) | ||
19-50045482-T-C | not specified | Uncertain significance (Jan 23, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ZNF473 | protein_coding | protein_coding | ENST00000595661 | 4 | 27701 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.262 | 0.738 | 125716 | 0 | 32 | 125748 | 0.000127 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.55 | 395 | 492 | 0.803 | 0.0000275 | 5846 |
Missense in Polyphen | 56 | 75.653 | 0.74022 | 771 | ||
Synonymous | 0.274 | 183 | 188 | 0.975 | 0.0000114 | 1558 |
Loss of Function | 3.85 | 7 | 29.7 | 0.236 | 0.00000152 | 372 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000867 | 0.0000867 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.000370 | 0.000370 |
European (Non-Finnish) | 0.0000616 | 0.0000615 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000359 | 0.000327 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in histone 3'-end pre-mRNA processing by associating with U7 snRNP and interacting with SLBP/pre-mRNA complex. Increases histone 3'-end pre-mRNA processing but has no effect on U7 snRNP levels, when overexpressed. Required for cell cycle progression from G1 to S phases. {ECO:0000269|PubMed:11782445, ECO:0000269|PubMed:16714279, ECO:0000269|PubMed:16914750}.;
- Pathway
- Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs;Metabolism of RNA;Processing of Capped Intronless Pre-mRNA;Cleavage of Growing Transcript in the Termination Region ;RNA Polymerase II Transcription Termination;SLBP independent Processing of Histone Pre-mRNAs
(Consensus)
Recessive Scores
- pRec
- 0.0761
Intolerance Scores
- loftool
- 0.513
- rvis_EVS
- 1.61
- rvis_percentile_EVS
- 95.91
Haploinsufficiency Scores
- pHI
- 0.0530
- hipred
- N
- hipred_score
- 0.485
- ghis
- 0.401
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.727
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Zfp473
- Phenotype
Gene ontology
- Biological process
- regulation of transcription, DNA-templated;termination of RNA polymerase II transcription;mRNA 3'-end processing by stem-loop binding and cleavage;histone mRNA metabolic process
- Cellular component
- nucleus;nucleoplasm;Cajal body
- Molecular function
- DNA binding;protein binding;metal ion binding